Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis

Journal of Urology

Volumn 185, Issue 5, 2011, Pages 1716-1721

  Evans, R J ^a   Moldwin, R M ^b   Cossons, N ^c   Darekar, A ^c   Mills, I W ^c   Scholfield, D ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b The Arthur Smith Institute for Urology   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

antibodies; cystitis; interstitial; nerve growth factor; pain; tanezumab

Indexed keywords

NERVE GROWTH FACTOR; PLACEBO; TANEZUMAB;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYSTALGIA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERESTHESIA; INTERSTITIAL CYSTITIS; INTERSTITIAL CYSTITIS SYMPTOM INDEX; MAJOR CLINICAL STUDY; MALE; MICTURITION; MULTICENTER STUDY; NEUROLOGIC DISEASE; PAIN ASSESSMENT; PARALLEL DESIGN; PARESTHESIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SINGLE DRUG DOSE; URINARY TRACT DISEASE; URINARY URGENCY; URINE VOLUME; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; CYSTITIS, INTERSTITIAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PLACEBOS; QUESTIONNAIRES; RECEPTOR, NERVE GROWTH FACTOR; TREATMENT OUTCOME;

EID: 79953767729     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.12.088     Document Type: Article

References (22)

1. A. Driscoll, and J.M. Teichman How do patients with interstitial cystitis present? J Urol 166 2001 2118
2. J.F. Metts Interstitial cystitis: urgency and frequency syndrome Am Fam Physician 64 2001 1199
3. S.H. Berry, M.A. Stoto, and M. Elliott Prevalence of interstitial cystitis/painful bladder syndrome in the United States J Urol 181 2009 20
4. R.J. Evans Treatment approaches for interstitial cystitis: multimodality therapy Rev Urol 4 2002 S16
5. J.D. Lilly, and C.L. Parsons Bladder surface glycosaminoglycans is a human epithelial permeability barrier Surg Gynecol Obstet 171 1990 493
6. C.L. Parsons The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis Urology 69 2007 9
7. F.F. Hefti, A. Rosenthal, and P.A. Walicke Novel class of pain drugs based on antagonism of NGF Trends Pharmacol Sci 27 2006 85
8. L. Delafoy, F. Raymond, and A.M. Doherty Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity Pain 105 2003 489
9. K. Lamb, Y.M. Kang, and G.F. Gebhart Nerve growth factor and gastric hyperalgesia in the rat Neurogastroenterol Motil 15 2003 355
10. S.I. Jaggar, H.C. Scott, and A.S. Rice Inflammation of the rat urinary bladder is associated with a referred thermal hyperalgesia which is nerve growth factor dependent Br J Anaesth 83 1999 442
11. C.L. Parsons, J. Dell, and E.J. Stanford Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity Urology 60 2002 573
12. M.P. O'Leary, G.R. Sant, and F.J. Fowler Jr The interstitial cystitis symptom index and problem index Urology 49 1997 58
13. K.G. Halvorson, K. Kubota, and M.A. Sevcik A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone Cancer Res 65 2005 9426
14. N.E. Lane, T.J. Schnitzer, and C.A. Birbara Tanezumab for the treatment of pain from osteoarthritis of the knee N Engl J Med 363 2010 1521
15. J.C. Nickel, D. Shoskes, and K. Irvine-Bird Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management J Urol 182 2009 155
16. T.C. Theoharides, and G.R. Sant Hydroxyzine therapy for interstitial cystitis Urology 49 1997 108
17. A. van Ophoven, S. Pokupic, and A. Heinecke A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis J Urol 172 2004 533
18. S.G. Mulholland, P. Hanno, and C.L. Parsons Pentosan polysulfate sodium for therapy of interstitial cystitis A double-blind placebo-controlled clinical study Urology 35 1990 552
19. C.L. Parsons, G. Benson, and S.J. Childs A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate J Urol 150 1993 845
20. G.R. Sant, K.J. Propert, and P.M. Hanno A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis J Urol 170 2003 810
21. J. Dimitrakov, K. Kroenke, and W.D. Steers Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review Arch Intern Med 167 2007 1922
22. A. van Ophoven, and L. Hertle Long-term results of amitriptyline treatment for interstitial cystitis J Urol 174 2005 1837